(2025). Clinical Outcomes of Drug Coated Balloons versus Drug Eluting Stents in Ostial Left Circumflex Coronary Lesions, Single Center Experience. test, 98(1), 511-516. doi: 10.21608/ejhm.2025.406782
. "Clinical Outcomes of Drug Coated Balloons versus Drug Eluting Stents in Ostial Left Circumflex Coronary Lesions, Single Center Experience". test, 98, 1, 2025, 511-516. doi: 10.21608/ejhm.2025.406782
(2025). 'Clinical Outcomes of Drug Coated Balloons versus Drug Eluting Stents in Ostial Left Circumflex Coronary Lesions, Single Center Experience', test, 98(1), pp. 511-516. doi: 10.21608/ejhm.2025.406782
Clinical Outcomes of Drug Coated Balloons versus Drug Eluting Stents in Ostial Left Circumflex Coronary Lesions, Single Center Experience. test, 2025; 98(1): 511-516. doi: 10.21608/ejhm.2025.406782

Clinical Outcomes of Drug Coated Balloons versus Drug Eluting Stents in Ostial Left Circumflex Coronary Lesions, Single Center Experience

The Egyptian Journal of Hospital Medicine
Article 74, Volume 98, Issue 1, January 2025, Pages 511-516    PDF (599.83 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2025.406782
Abstract
Background: Therapeutic management for isolated coronary stenosis involving the left anterior descending (LAD) or left circumflex artery (LCx) ostium is challenging. This is attributed to the unpredictable involvement of the distal left main (LM) coronary artery, as reported in a previous intravascular ultrasound (IVUS) study.
Aims and objectives: To compare between stenting ostial left circumflex artery lesions (LCx) vs drug coated balloon as single center experience with impact on Major adverse cardiac events after 6 months.  
Subjects and methods: This retrospective study was conducted at Cardiology Department, Zagazig University Hospitals. This study was done on 88 patients who were divided into 2 groups: Drug-coated balloon group: 44 patients and drug-eluting stent group: 44 patients.
Result: Significant differences were found in left ventricular ejection fraction, previous PCI history, coronary dissection after Drug Coated Ballon Angioplasty (DCBA) post-intervention Minimal Lumen diameter(MLD) , acute lumen gain, target lesion revascularization and Major Adverse Cardiac Events(MACE), Highly significant differences were observed in maximum pre-dilation balloon diameter, Drug coated  ballon /Drug Eluting Stents (DCB/DES) length and number, inflation pressure, follow-up MLD, and late lumen loss.
Conclusion: DCB was connected with lower long-term risks of Target Lesion Revascularization(TLR) and MACEs. It is suggested that use of the DCB strategy alone or usage of the hybrid strategy is safe and effective for the treatment of de novo ostial LCx lesions with a low technical threshold and a high success rate.
Keywords
Stenting ostial left circumflex artery lesions; Drug coated ballon; Single center experience; MACE
Statistics
Article View: 138
PDF Download: 74